Furthermore, purified cathepsin S was able to invoke facial nociception in vivo, also in an activity-dependent and PAR2-dependent manner, suggesting that cathepsin S would be capable of provoking oral cancer pain. This evidence concerns the gene F2RL1 and lip and oral cavity carcinoma.